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Abstract 
This review covers basic aspects of histone modification and the role of posttranslational histone modifications in the 
development of allergic diseases, including the immune mechanisms underlying this development. Together with 
DNA methylation, histone modifications (including histone acetylation, methylation, phosphorylation, ubiquitina-
tion, etc.) represent the classical epigenetic mechanisms. However, much less attention has been given to histone 
modifications than to DNA methylation in the context of allergy. A systematic review of the literature was undertaken 
to provide an unbiased and comprehensive update on the involvement of histone modifications in allergy and the 
mechanisms underlying this development. In addition to covering the growing interest in the contribution of histone 
modifications in regulating the development of allergic diseases, this review summarizes some of the evidence sup-
porting this contribution. There are at least two levels at which the role of histone modifications is manifested. One is 
the regulation of cells that contribute to the allergic inflammation (T cells and macrophages) and those that partici-
pate in airway remodeling [(myo-) fibroblasts]. The other is the direct association between histone modifications and 
allergic phenotypes. Inhibitors of histone-modifying enzymes may potentially be used as anti-allergic drugs. Further-
more, epigenetic patterns may provide novel tools in the diagnosis of allergic disorders.
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Background
In the last few decades, there has been a substantial 
increase in the prevalence of allergic diseases in the 
industrialized countries [1–3]. Since this change could 
not be explained by a rather stable population genetic 
profile [2–4], increased exposure to harmful and reduced 
exposure to protective epigenetically-mediated envi-
ronmental factors have been considered, at least in 
part, as a possible explanation for this epidemiological 
phenomenon [5–9]. While DNA methylation has been 
extensively studied as the epigenetic mechanism involved 
in the etiopathogenesis of allergic disorders, posttrans-
lational histone modifications, another important clas-
sical epigenetic mechanism, have not been as widely 
investigated and discussed because it is not considered 
as important as DNA methylation [5–7, 10]. The review 
firstly describes the (bio-) chemical basics of epigenetic 
histone modifications. This is followed by an assessment 
of recent evidence that supports a role for histone modifi-
cations in the epigenetic regulation of the pathogenesis of 
allergy and related disorders, together with a description 
of the underlying cellular and molecular mechanisms.
Main text
Histone modifications: the basics
Similarly to DNA methylation, posttranslational histone 
modifications do not affect DNA nucleotide sequence but 
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can modify its availability to the transcriptional machin-
ery. Although histone modifications play also other roles, 
such as histone phosphorylation, best known for its 
contribution to DNA repair in response to cell damage, 
this review deals primarily with general mechanisms of 
histone modifications in the context of their role in epi-
genetic modulation of gene expression. Several types of 
histone modifications are known, amongst which acety-
lation, methylation, phosphorylation, and ubiquitination 
are the best studied and most important in terms of the 
regulation of chromatin structure and (transcriptional) 
activity [11–15]. In general, histone modifications are 
catalyzed by specific enzymes that act, predominantly, 
but not exclusively (e.g. some types of histone phospho-
rylation), at the histone N-terminal tails involving amino 
acids such as lysine or arginine as well as serine, threo-
nine, tyrosine, etc. Histone acetylation usually leads to 
higher gene expression. This may not always be the case 
for histone H4 [16–18]. Histone methylation in turn has 
either transcriptionally permissive or repressive charac-
ter, depending on the location of targeted amino acid res-
idues in the histone tail and/or the number of modifying 
(e.g. methyl) groups added [5, 6, 14, 15, 19, 20]. Table 1 
summarizes the various forms of histone modifications 
appearing in this review along with their effects on gene 
transcriptional activity.
Histone acetylation
Histone acetylation status is regulated by two groups of 
enzymes exerting opposite effects, histone acetyltrans-
ferases (HATs) and histone deacetylases (HDACs). HATs 
catalyze the transfer of an acetyl group from acetyl-CoA 
to an amino acid group of the target lysine residues in 
the histone tails, which leads to the removal of a posi-
tive charge on the histones, weakening the interaction 
between histones and (negatively charged phosphate 
groups of ) DNA. This in turn typically makes the chro-
matin less compact and thus more accessible to the tran-
scriptional machinery. HDACs remove acetyl groups 
from histone tail lysine residues and thereby work as 
repressors of gene expression [5, 14, 21–24].
HATs are classified into five (or sometimes six) fami-
lies. The GCN5-related N-acetyltransferase (GNAT) 
family comprises KAT2A and KAT2B enzymes. They 
are involved in acetylation of histones and transcription 
Table 1 List of histone modifications appearing in this review along with their effects on the transcriptional activity
a According to the cells signaling technology webpage [100] and/or other sources referenced in the “Main text” and/or Tables 2 and 3 of this review
b See also “Histone modifications: the basics”
Modification and site Abbreviation Effect on  transcriptiona
Histone acetylation
 Histone 3 panacetylation H3ac Activating/permissive
 Histone 4 panacetylation H4ac Activating/permissiveb
 Histone 3 lysine 4 acetylation H3K4ac Activating/permissive
 Histone 3 lysine 9 acetylation H3K9ac Activating/permissive
 Histone 3 lysine 14 acetylation H3K14ac Activating/permissive
 Histone 3 lysine 18 acetylation H3K18ac Activating/permissive
 Histone 3 lysine 27 acetylation H3K27ac Activating/permissive
 Histone 4 lysine 16 acetylation H4K16ac Activating/permissive
Histone methylation
 Histone 3 lysine 4 methylation H3K4me1 Activating/permissive
 Histone 3 lysine 4 dimethylation H3K4me2 Activating/permissive
 Histone 3 lysine 4 trimethylation H3K4me3 Activating/permissive
 Histone 3 lysine 9 dimethylation H3K9me2 Repressive
 Histone 3 lysine 9 trimethylation H3K9me3 Repressive
 Histone 3 lysine 27 trimethylation H3K27me3 Repressive
 Histone 3 lysine 36 trimethylation H3K36me3 Activating/permissive
 Histone 3 lysine 79 methylation H3K79me1 Activating/permissive
Histone phosphorylation
 Histone 3 serine 10 phosphorylation H3S10ph Activating/permissive
Histone ubiquitination
 Histone 2A ubiquitination H2Aub Repressive
 Histone 2B ubiquitination H2Bub Activating/permissive
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Table 3 Studies on the role of histone modifications in allergic diseases meeting the secondary selection criteria
Study Major epigenetic findings (in the context of major study results)
Zhong et al. [102] Significantly decreased expression of Th2-related cytokines (IL-4, IL-5) in human CD4+ T-cells and PBMCs was observed after 
transfection with chemically synthesized PIWI interacting RNA (piRNA), piR30840. Accordingly, antisense inhibition of the 
endogenous piR30840 resulted in CD4+ T-cells with upregulated IL-4 expression. As no differences in histone methyla-
tion levels at the IL4 promoter region between piR30840-transfected and -untransfected CD4+ T-cells were detected, the 
functioning of piR30840 was not attributed to this type of histone modification but rather to pre-mRNA decay through 
nuclear exosomes
Zheng et al. [103] After treatment with TSA, a significant increase of the (lower) transcription of STAT3-dependent genes (IL17A and IL22) in 
IL-23-stimulated PBMCs from chronic mucocutaneous candidiasis (CMC) patients (n = 16) (back) to control (n = 37) levels 
was observed. Conversely, TSA significantly decreased the enhanced transcription of STAT1-dependent genes (CXCL10 and 
IRF1) in IFN-α-stimulated gain-of-function STAT1-mutation Epstein-Barr virus (EBV)-transformed B cell line back to control 
levels
Vicente et al. [104] Noticeable regulatory activity characterized by H3K4me1/2 peak identified four putative regulatory elements (PREs) in 
the 8q21 core region of genetic association (with allergies) in lymphoblastoid cells. Significant correlation between the 
allergy-associated SNP rs7009110 located on the 8q21 and PAG1 expression
Naranbhai et al. [105] Significant enrichment of peak cis-eQTL was detected in DNA-hypomethylated regions, and in regions marked by H3K4me3 
(associated with promoter activity), H3K27ac and H3K4me1 (associated with active or poised enhancers), and H3K36me3 
(associated with gene activation) in neutrophils. Correspondingly, a depletion of peak cis-eQTL was observed in DNA-
hypermethylated regions and in regions marked by H3K27me3 and H3K9me3 (repressive histone modifications). A SNP 
rs2240335, an eQTL in PADI4 (a locus associated with rheumatoid arthritis), was shown to be located within regions 
marked by H3K27ac and H3K4me1
Lin et al. [106] Increased H4ac levels at the VCAM1 promoter region correlating with higher VCAM1 expression (protein/mRNA) and pro-
moter activity in human tracheal smooth muscle cells were observed upon pretreatment with ET-1, mediated via Elk-1/
p300 interaction, in an ET receptor/Src/RTK/PI3K/AKT/p42/p44 MAPK-dependent manner
Castellucci et al. [70] Ablation of the IL-10-mediated deacetylation of H4ac at the CXCL8 promoter in LPS-stimulated monocytes was observed 
after CI-994, a class I HDACi, treatment. Concordantly, IL-10-mediated inhibition of CXCL8 transcription in LPS-stimulated 
PBMCs obtained from COPD patients (n = 6), due to reduced HDAC2 expression, was dampened compared to acute 
respiratory failure patients (n = 4) and healthy controls (n = 6)
Hsieh et al. [71] Noticeable suppression of the LPS-induced MDC/CCL22 expression in THP-1 cells (human monocyte cell line) and human 
primary monocytes was observed after treatment with sesamin, a class of phytoestrogen isolated from sesame seed 
Sesamum indicum, due to dampened recruitment of a HAT, CREBBP, and a subsequent decrease in H3ac and H4ac levels at 
the CCL22 promoter
Sharma et al. [107] Significant enrichment of active histone marks H3K4me1 and H3K27ac at the regions near to two asthma-associated SNPs in 
the FADS2 (rs968567) and the NAGA (rs1801311) loci was observed in three different cell lines: Jurkat (human T lymphocyte 
cell line), Beas-2B (human bronchial epithelial cell line) and A549 (human lung epithelial cell line). Consistently, both SNPs 
showed significant enrichment of formaldehyde-assisted isolation of regulatory elements (FAIRE) signals in all three cell 
lines
Escobar et al. [108] Markedly increased Jumonji, AT Rich Interactive Domain 2 (Jarid2), a DNA-binding protein that recruits the polycomb 
repressive complex 2 (PRC2) to chromatin, and H3K27me3 islands were detected throughout the genome (among other 
regions, within 10 kb of the Il22, Il10, and Il9 loci) in miR-155-deficient compared to wild-type mouse Th17 cells
Huber et al. [74] Significantly elevated levels of the repressive H3K27me3 mark at the conserved noncoding sequence (CNS-1) located 5 kb 
upstream of exon 1A of the GATA3 gene in primary naïve human CD4+ T-cells after treatment with IFN-α (both, with 
or without IL-4 co-stimulation) were observed, resulting in a consequential inhibition of GATA3 binding to exon 1A (i.e. 
down-regulation of a positive-feedback loop of GATA3/GATA3 autoactivation and thus reduced gene expression)
Gschwandtner et al. [109] When compared to both neonatal and adult human keratinocytes (KCs), fetal human KCs produced more AMPs, and had 
lower global H3K27me3 levels and higher expression of a histone demethylase JMJD3. JMJD3 knockdown with siRNA led 
to an increase in H3K27me3 levels and lower AMP production
Coward et al. [58] Markedly increased H3K9me3 and H3K27me3 levels at the COX2 promoter were detected in primary human fibroblasts from 
IPF lung (stimulated or not with the COX2 inducer, IL-2β) when compared to fibroblasts from non-fibrotic lung, which 
were related to the recruitment of HMTs, G9a and EZH2. Substantially decreased H3K9me3 and H3K27me3, and increased 
H3ac and H4ac levels at the COX2 promoter resulting in COX2 mRNA and protein re-expression were observed in fibro-
blasts from IPF lung after treatment with G9a or EZH2 inhibitors (more significant effect with IL-2β stimulation)
Sanders et al. [59] Markedly increased H3K9ac and decreased H3K9me3 at the pro-apoptotic BAK1 gene accompanied with increased expres-
sion (mRNA) and substantially decreased H3K9ac and increased H3K9me3 levels at the anti-apoptotic BCL2L1 gene 
accompanied by a decrease in gene expression (mRNA) were observed in primary human IPF fibroblasts after treatment 
with a HDACi, SAHA
Han et al. [110] Significantly reduced H3K27me3 levels at the ALOX15 promoter were detected in A549 cells after treatment with IL-4, coin-
ciding with higher ALOX15 mRNA levels. More potent induction of ALOX15 was observed in human monocytes. Significant 
increase in H3K27me3 levels after depletion of a lysine demethylase UTX (with siRNA) was observed, resulting in reduced 
IL-4-induced ALOX15 expression. Inhibition of the IL-4-mediated ALOX15 expression in UTX-depleted human monocytes 
with no changes in the H3K27me3 levels when compared to control monocytes was found
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Table 3 (continued)
Study Major epigenetic findings (in the context of major study results)
Lakshmi et al. [111] Markedly reduced expression of PPARy correlated with downregulated HDAC2 expression in lung and human bronchial epi-
thelial cells (HBE) obtained from COPD patients compared with healthy controls. Noticeable suppressed GR-α expression 
in H292 cells (human lung epithelial cell line) after CSE treatment due to dampened expression of PPARy and HDAC2 was 
also observed. The suppressive effect of CSE on GR-α and HDAC expression was attenuated with PPARy agonists
Zhang et al. [60] Downregulation of COL3A1 expression in primary human IPF myofibroblasts with concomitant increases of H3ac, H4ac, 
H3K9ac, and H3K27me3 levels at COL3A1 promoter was observed after SAHA treatment
Wiegman et al. [112] Significantly increased HAT activity levels and decreased HDAC2 activity levels (due to protein modification: nuclear phos-
phorylation and cytoplasmic carbonylation) were observed in lung extracts obtained from mice after ozone exposure 
compared to air-exposed animals
Che et al. [113] Inhibition of the sphingosine-1-phosphate (S1P)-induced IL-6 secretion by primary human ASMCs via MKP-1-mediated 
repression of MAPK-driven activation of mitogen and stress-activated protein kinase 1 (MSK1) and phosphorylation at 
H3S10 (H3S10ph; global; putatively at IL6 promoter as well) was observed after the treatment of the cells with dexametha-
sone
Liu et al. [61] Significantly higher H3K9ac levels at the TERT promoter region were detected in primary human lung fibroblasts from 
patients with IPF (n = 70) compared with healthy control subjects (n = 117). After treatment of the cells with a HDACi 
(TSA), significantly elevated TERT mRNA and TERT protein levels (time and dose-dependent increase) were detected in 
both human lung fibroblasts from patients with IPF and mouse lung fibroblasts from a murine model of bleomycin-
induced pulmonary fibrosis
Gerasimova et al. [75] Noticeable enrichment of asthma-associated non-coding SNPs and H3K4me1 peaks (enhancers) in the Th2 cytokine locus 
of CD4+ T-cells (when compared with other cell/tissue types) was observed
Li et al. [76] Significantly decreased LAT expression consistent with decreased H3ac and H4ac levels and increased H3K9me2 levels at 
the LAT (Lat) upstream region in lung T-cells obtained from ovalbumin-induced allergic airway inflammation rat model 
when compared with control animals were found. H3ac and H4ac as well as LAT expression noticeably increased after 
treatment of the cells with TSA
Luo et al. [77] Increased global H3ac and H3K4me levels were observed in PBMCs of HSP patients with kidney damage (n = 16) compared 
to HSP patients without kidney damage (n = 8) and healthy controls (n = 22). Higher CD4 + T-cell H3ac and H3K4me3 lev-
els were detected at IL4 regulatory regions of HSP patients when compared to control subjects. Higher expression (mRNA) 
of several HATs (CREBBP, PCAF, and p300) and HMTs (SETD1A, SETDB1, SUV39H1, and SUV39H2) and lower expression of a 
few HDACs (HDAC1, HDAC2, HDAC3, and SIRT1) were found in PBMCs of both HSP groups compared to healthy controls
Kallsen et al. [114] Markedly increased H3ac and H3K4me3 levels at the DEFB1 promoter in A549 cells coinciding with enhanced DEFB1 expres-
sion after treatment with class I HDACi (MS-275) were found
Han et al. [78] Noticeable DNA hypomethylation at 26 unique regions (10–70 kb) was found in naïve CD4+ T-cells obtained from psoriasis 
patients (n = 12) compared to atopic dermatitis patients (n = 15) and healthy controls (n = 10). These regions coincided 
incidentally with various strong epigenomic signals, including histone modifications (H3K4me1, H3K27ac, and H3K4me3), 
and transcription factor binding sites
Robertson et al. [115] Significantly increased HDAC activity (only at the protein level) was observed in ARNT-depleted N-TERT keratinocytes 
(15–20% increase) and in ARNT-depleted immortalized human HaCaT keratinocytes (~ 50% increase). After treating ARNT-
depleted N-TERT keratinocytes with TSA, the negative effect of ARNT-deficiency on transcription of amphiregulin gene 
(AREG), an important ligand of EGFR, was abolished
Vazquez et al. [116] A novel inducible hypersensitive region was identified in human and mouse lymphocytes that is located in intron I of CD69. 
H3K4me2, H3ac, H3K14ac, and/or H3K4ac levels within this region were found to be dynamically regulated during thymo-
cyte development and/or to be constitutively high in mature T lymphocytes
Zijlstra et al. [117] Reduced glucocorticoid sensitivity and dampened HDAC activity were observed in 16HBE cells (human bronchial epithelial 
cell line) after treatment with IL-17A. Overexpression of HDAC2 reversed IL-17A-induced glucocorticoid insensitivity
For criteria of the selection, please, refer to Fig. 1 and “Systematic search: methodology” section of “Main text”
ALOX15, arachidonate 15-lipoxygenase (ALOX15) gene; AMP, antimicrobial peptide; ARNT, aryl hydrocarbon receptor nuclear translocator; BAK1, BCL2 antagonist/
killer (Bak) gene; Bcl-xL, B-cell lymphoma-extra large (Bcl-xl) gene; CBP, CREB binding protein; COL3A1, collagen type III alpha 1 chain (COL3A1) gene; COPD, chronic 
obstructive pulmonary disease; CREBBP, CREB binding protein; CSE, cigarette smoke extract; DEFB1, defensin beta 1 (DEFB1) gene; eQTL, expression quantitative trait 
loci; Elk-1, ETS transcription factor; ET-1, endothelin-1; EZH2, enhancer of zeste 2 polycomb repressive complex 2 subunit; FADS2, fatty acid desaturase 2 (FAD2) gene; 
GR-α, glucocorticoid receptor alpha; HMT, histone methyltransferase; HSP, Henoch-Schönlein purpura; IL17A/22, interleukin 17A/22 (IL-17A/-22) gene; Il9/10/22; mouse 
interleukin 9/10/20 (il-9/-10/-22) gene; IL-23/2β, interleukin 23/2β; INF-α, interferon alpha; IPF, Idiopathic pulmonary fibrosis; IRF1, interferon regulatory factor 1; LAT, 
linker for activation of T-cells; MDC/CCL22, macrophage-derived chemokine/C–C motif chemokine ligand 22 (CCL22) gene; NAGA , alpha-N-acetylgalactosaminidase 
(NAGA) gene; PADI4, peptidyl arginine deiminase 4 (PADI4) gene; PAG1, phosphoprotein membrane anchor with glycosphingolipid microdomains 1 (PAG1) gene; 
PCAF, lysine acetyltransferase 2B; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; PPARy, peroxisome proliferator activated receptor gamma; RTK, Receptor 
tyrosine kinase; SAHA, suberoylanilide hydroxamic acid; siRNA, small interfering RNA; SNP, single-nucleotide polymorphism; Src, SRC proto-oncogene, non-receptor 
tyrosine kinase; TERT, telomerase transcriptase (TERT) gene; VCAM1, vascular cell adhesion molecule-1 (VCAM-1) gene
For the remaining abbreviations please refer to Tables 1 and 2
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factors and thus cell cycle regulation, and DNA replica-
tion and repair [25, 26]. Moreover, these enzymes have 
been recently identified to be important for centro-
some function as well [27]. The MYST family is in turn 
composed of KAT6A/MOZ/MYST3, KAT6B/MORF/
MYST4, KAT7/HBO1/MYST2, KAT8/hMOF/MYST1, 
and KAT5/Tip60. It contributes to transcription regu-
lation and is also responsible for DNA repair [28–30]. 
Interestingly, autoacetylation of MYST family protein 
enzymes participates in their regulation, which makes 
them distinct from other acetyltransferases, drawing 
at the same time similarities to the phosphoregulation 
of protein kinases [31, 32]. The other HAT families are 
much smaller. KAT3A and KAT3B enzymes belong to 
p300/CBP family, and KAT4/TAF1/TBP and KAT12/
TIFIIIC90 are members of the general transcriptional 
factor-related HAT family [23, 28, 33]. Steroid receptor 
co-activators family comprises KAT13A/SRC1, KAT13B/
SCR3/AIB1/ACTR, KAT13C/p600, and KAT13D/
CLOCK [23, 34]. Finally, KAT1/HAT1 and HAT4/
NAA60 are cytoplasmic HATs [23].
Eighteen enzymes belonging to the HDAC superfam-
ily have been identified. They are further subdivided into 
four classes, including class I (HDAC1, HDAC2, HDAC3, 
and HDAC8), class IIa (HDAC4, HDAC5, HDAC7, and 
HDAC9), class IIb (HDAC6 and HDAC10), class III, so-
called sirtuins (SIRTs; SIRT 1–7; enzymes evolutionally 
and mechanistically different from the other HDACs), 
and class IV (HDAC11) [35–37]. Class I HDACs are 
characterized by a ubiquitous nuclear expression in all 
tissues, class IIb HDACs are present both in the nucleus 
and cytoplasm, and class IIa HDACs show mainly cyto-
solic localization. Not much is known about HDAC11, 
and sirtuins which localize in nucleus, cytosol and/or 
mitochondria [36].
Histone methylation
Histone methylation is mediated by histone methyl-
transferases (HMTs), including lysine methyltransferases 
(KMTs) and arginine methyltransferases (PRMTs), and 
histone demethylation by histone demethylases (HDMs).
Whereas acetylation of the histone lysine affects the 
electrical charge of the histones and thus their interac-
tion with DNA, methylation of histone lysine or arginine 
does not affect this electrostatic bond, but instead indi-
rectly influences the recruitment and binding of differ-
ent regulatory proteins to chromatin [19, 38, 39]. HMTs 
can transfer up to three methyl groups from the cofac-
tor S-adenosyl-l-methionine (SAM) to lysine or arginine 
residues of the histones [19, 38]. More than 50 human 
KMTs are known at the moment, which, based on their 
catalytic domain sequence, can be further subdivided 
into the SET domain-containing and the DOT1-like 
protein family, the latter having only one representative 
in humans, with a catalytic domain structurally more 
similar to the PRMTs [19, 38, 39]. KMTs are more spe-
cific than HATs and they generally target a specific lysine 
residue. Methylation of H3K4 residue (for the description 
of histone modifications including their location, charac-
ter and effect on transcription, please, refer to Table 1) is 
mediated in mammals by KMTs such as KMT2A/MLL1, 
KMT2A/MLL2, KMT2F/hSET1A, KMT2G/hSET1B, 
or KMT2H/ASH1. Examples of KMTs responsible for 
H3K9 methylation include KMT1A/SUV39H1, KMT1B/
SUV39H2, KMT1C/G9a, or KMT1D/EuHMTase/GLP. 
H3K36 methylation is catalyzed by e.g. KMT3B/NSD1, 
KMT3C/SMYD2, or KMT3A/SET(D)2. KMT6A/EZH2 
methylates H3K27, andKMT4/DOT1L targets H3K79. 
Etc. [19, 38, 39].
Based on the catalytic mechanism and sequence 
homology, HDMs can be divided into two classes. 
Firstly, amine-oxidase type lysine-specific demethylases 
(LSDs or KDM1 s), including KDM1A/LSD1/AOF2 and 
KDM1B/LSD2/AOF1. These remove the methyl groups 
from mono- and dimethylated H3K4. Secondly, the 
JumonjiC (JMJC) domain-containing HDMs, in turn, cat-
alyze the demethylation of mono-, di-, and trimethylat-
edlysine residues at various histone amino acid residues. 
Over thirty members of this group can be further subdi-
vided, based on the JMJC domain homology, into seven/
eight subfamilies (KDM2–7/8) [19, 38–41].
Histone phosphorylation
Histone phosphorylation status is controlled by two 
types of enzymes having opposing modes of action. 
While kinases add phosphate groups, phosphatases 
remove the phosphates [13, 15]. At least three functions 
of phosphorylated histones are known, DNA damage 
repair, the control of chromatin compaction associated 
with mitosis and meiosis, and the regulation of tran-
scriptional activity (similar to histone acetylation) [13, 
15]. In comparison to histone acetylation and methyla-
tion, histone phosphorylation works in conjunction with 
other histone modifications, establishing the platform for 
mutual interactions between them. This cross-talk results 
in a complex downstream regulation of chromatic status 
and its consequences [13, 15, 42]. For example, histone 
H3 phosphorylation (specifically H3S10ph) can directly 
affect acetylation levels at two amino acid residues of the 
same histone (H3K9ac and H3K14ac) [43, 44]. Further-
more, H3S10ph can induce transcriptional activation by 
interaction with H4K16ac [42].
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Histone ubiquitination
Protein ubiquitination is an important post-translational 
modification that regulates almost every aspect of cellu-
lar function in many cell signaling pathways in eukary-
otes. Ubiquitin is an 8.5 kD protein which is conjugated 
to substrate proteins by the ubiquitin–proteasome sys-
tem thereby regulating the stability and turnover of the 
target proteins. Histone ubiquitination is carried out by 
histone ubiquitin ligases and can be removed by ubiq-
uitin-specific peptidases, the latter known as deubiqui-
tinating enzymes (DUBs) [45–47]. Monoubiquitination 
has a critical role in protein translocation, DNA dam-
age signaling, and transcriptional regulation. Histone 2A 
monoubiquitination (H2Aub) is more often associated 
with gene silencing. Monoubiquitination of histone 2B 
(H2Bub) is typically correlated with transcription activa-
tion. Polyubiquitination marks the protein for degrada-
tion or activation in certain signaling pathways [45–48]. 
Similarly to histone phosphorylation, there is also cross-
talk between histone ubiquitination and other histone 
modifications [46–48]. For instance, monoubiquitination 
of histone H3 is able to induce acetylation of the same 
histone [49].
Epigenetic readers
In addition to epigenetic writers, i.e. enzymes add-
ing epigenetic marks on histones (HATs, HMTs/KMTs, 
PRMTs, kinases, ubiquitin ligases) and epigenetic erasers 
(HDACs, HDMs/KDMs, phosphatases, DUBs), there are 
also epigenetic readers, which are the molecules that rec-
ognize and bind to the epigenetic marks created by writ-
ers, thereby determining their functional consequences. 
They include proteins containing bromodomains, chro-
modomains, or Tudor domains [50, 51]. Some enzymes 
with primary activities different from epigenetic reading 
possess bromodomains as well, for example certain HATs 
[51].
Systematic search: methodology
In order to cover the area of interest, a systematic lit-
erature search was conducted (Fig.  1). In brief, On 
January 23, 2017, the PubMed database (http://www.
ncbi.nlm.nih.gov/pubme d) was searched by using the 
input “(allergy OR atopy OR asthma OR dermatitis OR 
eczema OR food allergy OR rhinitis OR conjunctivi-
tis) AND (histone modifications OR histone modifica-
tion OR histone acetylation OR histone methylation OR 
histone phosphorylation OR histone ubiquitination)”, 
restricting the results with “5 years” (“Publication dates”) 
and “Humans” (“Species”) filters, which yielded a total 
of 170 hits. These were subsequently subjected to full 
text-based screening to exclude articles not reporting 
original data (reviews, editorials, commentaries, etc.), 
which resulted in elimination of 54 publications. From 
the remaining 116 papers, a further 72 were excluded 
as not being directly or at least indirectly relevant to the 
topic of the present review (not reporting data on his-
tone modifications, reporting histone modification data 
but not in the context of allergic or related disorders, or 
both). The remaining 44 articles were divided into two 
groups. The group that met the primary selection crite-
rion contained 17 papers reporting the data on the role 
of histone modifications in allergic diseases obtained in 
material collected from allergic subjects and thus directly 
relevant to allergies is presented in Table 2. Another 27 
articles of potential interest comprised the additional 
group (Table 3). These did not necessarily target allergic 
disorders but allergy-like diseases or related conditions, 
did not report histone modification data obtained in pri-
mary human cells/tissues, or indeed a combination of 
those. This included also those reporting data on epige-
netic mechanisms likely playing a role in allergies but not 
directly related to/associated with this group of diseases.
Systematic search: review
Epigenetic mechanisms are thought to play an important 
regulatory role in allergic inflammation and the develop-
ment of allergic disorders. DNA methylation is the clas-
sical epigenetic modification that has been most widely 
studied in this context. However, histone modifications, 
which contribute to the lineage commitment, differen-
tiation and maturation of immune cells, including those 
strongly involved in allergic inflammation such as CD4+ 
T-helper (Th) cells, are likely to play a crucial role in the 
predisposition to developing atopic diseases as well as in 
the effector phase of allergic inflammation [5, 6, 10, 52, 
53]. Indeed, our systematic search identified a number 
of recent studies that sought to define the relationships 
between histone modifications and allergic inflammation 
or related immune mechanisms, and/or allergic diseases 
or disorders sharing some of the pathophysiology. The 
results reported in those 44 original articles are summa-
rized in Tables 2 and 3.
Several studies investigated the relationships between 
histone modifications in airway smooth muscle cells 
(ASMCs) and the respiratory tract allergic inflammatory 
disease. For instance, increased binding of bromodo-
main-containing HATs [E1A binding protein p300 (p300) 
and p300/CBP-associated factor (PCAF)] accompanied 
by significantly higher H3ac levels (specifically H3K18ac) 
at the C–X–C motif chemokine ligand 8 (CXCL8) gene 
(CXCL8) promoter were observed in ASMCs obtained 
from asthmatics compared to healthy controls [54]. 
Furthermore, treatment of cultured cells with bromo-
domain and extra-terminal (BET) protein inhibitors 
reduced CXCL8 secretion [54]. The application of BET 
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PubMed search:
i. For “(allergy OR atopy OR asthma OR dermatitis OR eczema
OR food allergy OR rhinitis OR conjunctivitis) AND (histone 
modifications OR histone modification OR histone acetylation
OR histone methylation OR histone phosphorylation
OR histone ubiquitination)”
ii. Using “5 years” (“Publication dates”) and “Humans” (“Species”) filters
iii. On January 23, 2017
170 Records
Excluded if:




i. Not reporting data on histone modifications
ii. Reporting histone modification data but not in the 
context of allergic or related disorders






As meeting primary criterion(Table 2) if:
i. Reporting the data on the role
of histone modifications
in allergic diseases obtained
in (martials collected from)
allergic subjects
27 Records
As meeting secondary criteria (Table 3),
of potential interest though:
i. Not really targeting allergic diseases
but allergy-like disorders or related conditions
ii. Not reporting the histone modification data
obtained in primary human cells/tissues
iii. A combination of those
iv. Reporting data on epigenetic mechanisms
(likely) playing a role in allergies
but not directly related to/associated
with this group of diseases
v. Others
Fig. 1 Strategy of systematic literature search and its results
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bromodomain mimics reduced in turn fetal calf serum 
plus transforming growth factor beta (TGF-β) -induced 
ASMC proliferation and interleukin 6 (IL-6) gene (IL6) 
and CXCL8 expression, with the required dose depend-
ing on asthma severity of cell donor [55]. On the other 
hand, no differences in H3ac and H4ac levels at the 
cytochrome c oxidase subunit II (COX2) gene (COX2) 
between the asthmatic and non-asthmatic ASMCs were 
detected, regardless of whether they were stimulated 
with proinflammatory cytokines [56]. Although asth-
matic and non-asthmatic ASMCs did not differ in their 
H3ac or H4ac levels at the vascular endothelial growth 
factor A (VEGF) locus (VEGFA), the cells obtained 
from affected individuals displayed slightly but consist-
ently higher H3K4me3 and a low H3K9me3 levels [57]. 
Moreover, treatment with an inhibitor of a HMT (HMTi), 
euchromatic histone-lysine N-methyltransferase 2 (G9a), 
increased VEGF expression in non-asthmatic ASMCs to 
near asthmatic levels [57].
Histone modifications at several of the above-men-
tioned loci contribute also to the pathophysiology of 
some other inflammatory disorders of the lung. For 
example, H3K9me3 and H3K27me3 levels at the COX2 
promoter were found to be substantially higher in pri-
mary human fibroblasts isolated from lung tissue of idi-
opathic pulmonary fibrosis (IPF) patients compared 
to non-IPF fibroblasts. This was accompanied by the 
recruitment of HMTs, G9a and enhancer of zeste 2 
polycomb repressive complex 2 subunit (EZH2) [58]. 
Interestingly, after treatment with G9a or EZH2 inhibi-
tors, the levels of H3K9me3 and H3K27me3 markedly 
decreased and H3ac and H4ac levels increased at the 
COX2 promoter [58]. Several other studies observed 
the involvement of histone modifications in the regu-
lation of gene expression in (human) IPF lung (myo-) 
fibroblasts, the effects of which were sensitive to HDAC 
inhibitor (HDACi) treatment [59–61]. Histone acetyla-
tion and/or methylation in (myo-) fibroblasts were also 
demonstrated to regulate expression of the loci involved 
in the pathogenesis of nasal chronic rhinosinusitis and 
polyposis, such as prostaglandin E receptor 2 (EP2) 
gene (PTGER2) [62]. Furthermore, HDACi treatment 
influenced HDAC expression and histone acetylation at 
several loci, thus affecting nasal polyp myofibroblast dif-
ferentiation and extracellular matrix production [63, 64]. 
Finally, although no differences in ADAM metallopepti-
dase domain 33 (ADAM33) gene (ADAM33) expression 
were observed between asthmatic and healthy control 
bronchial fibroblasts, treatment with TGF-β suppressed 
ADAM33 mRNA expression through chromatin conden-
sation related to deacetylation of H3ac, demethylation of 
H3K4, and hypermethylation of H3K9 at the ADAM33 
promoter [65]. Asthmatic and non-asthmatic histone 
acetylation levels were compared also in alveolar epithe-
lial cells [66]. Global H3K18ac and H3K9me3 levels were 
higher in cells from asthmatics, which was also the case 
for gene-specific H3K18ac (but not H3K9me3) around 
transcription start sites of the loci encoding tumor pro-
tein p63 (TP63; ∆Np63 isoform), epidermal growth fac-
tor receptor (EGFR), and signal transducer and activator 
of transcription 6 (STAT6) [66]. The latter effect was 
ablated upon HDACi treatment [66].
Several studies were conducted on the biology of 
monocytes, the mechanisms of epigenetic modulation 
controlling production of cytokines, and their role in 
the onset/severity of allergic diseases. H4ac levels at the 
glucocorticoid response element upstream of the dual 
specificity phosphatase 1 gene (DUSP1) encoding for 
MAPK phosphatase 1 (MKP-1) substantially increased in 
dexamethasone-treated cells obtained from both steroid-
sensitive and steroid-resistant asthmatics patients [67]. 
Furthermore, preincubation with calcitriol led to a signif-
icant enhancement of the dexamethasone-induced H4ac, 
with higher H4ac levels observed in monocytes obtained 
from steroid-sensitive than those from steroid-resistant 
individuals [67]. The involvement of histone acetylation 
or phosphorylation in regulation of gene expression in 
monocytes/macrophages was also demonstrated for C–C 
motif chemokine ligand 2/17/22 (CCL2/17/22), CXCL8, 
or IL6 loci [68–71]. In addition, in monocytes, histone 
modification changes were susceptible to pharmacologi-
cal modification ex  vivo, demonstrated by the effect of 
HDACi on CXCL8 H4ac levels [70].
Several studies have focused on T-cells. For example, 
differences in H3ac and H4ac levels at the interleukin 13 
(IL-13) gene (IL13) that were observed in CD4+ T-cells 
from children with allergic asthma and healthy controls 
correlated with serum IL-13 concentrations [72]. Dif-
ferential enrichment of H3K4me2 in 200 cis-regulatory/
enhancer regions in naïve, Th1, and Th2 CD4+ T-cells 
was observed between asthmatic and non-asthmatic 
subjects. Moreover, 163 of those 200 asthma-associated 
enhancers were Th2-specific and 84 of them contained 
binding sites for transcription factors involved in T cell 
differentiation [e.g. GATA binding protein 3 (GATA3), 
T-box 21 (TBX21) and RUNX3] [73]. Most of the other 
studies identified by our literature search were also sup-
portive for the importance of histone modifications, such 
as acetylation and methylation, in (CD4+) T-cell biol-
ogy and/or related pathophysiology of allergic disorders 
[74–78].
Some prenatal dietary exposures, previously demon-
strated to modulate the infant’s immune responses and/
or risk of allergy development in offspring [79–82], have 
recently been shown to be associated with the altera-
tions in histone acetylation profiles in neonatal cells. For 
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instance, cord blood (CB) CD4+ T-cells obtained from 
children born from mothers with highest serum folate 
levels during pregnancy were characterized by signifi-
cantly higher histone H3ac and H4ac levels at the GATA3 
gene (GATA3) promoter, markedly lower H4ac levels at 
the analogous region of the interferon gamma (IFNγ) 
gene (IFNG), and significantly higher interleukin-9 (IL-
9) gene (IL9) promoter H4ac levels when compared to 
the lowest folate level group [83]. In CB CD4+ T-cells 
obtained from newborns of mothers supplemented with 
fish oil (ω − 3 fatty acids) during pregnancy in turn, sig-
nificantly higher H3ac levels were observed at the pro-
tein kinase C zeta (PKCζ) gene (PRKCZ) and IFNG locus, 
and lower H3/H4ac levels at the IL-13 and TBX21 genes 
(IL13 and TBX21, respectively) [84]. The infants from the 
fish oil-supplemented women were found to have lower 
risk of developing allergic diseases [81, 82].
Both passive (prenatal and postnatal) and active 
tobacco smoke exposures are a well-known extrinsic 
factors affecting the risk of allergic disorders, especially 
asthma, and this effect was found to be associated with 
(and thus is thought to be at least partly mediated by) 
changes in DNA methylation patterns [5, 6]. Exposure to 
passive smoking diminished corticosteroid sensitivity of 
alveolar macrophages obtained from children with severe 
asthma and was accompanied by lower HDAC2 expres-
sion and activity. This possibly explains the unfavorable 
effect [85] and suggests that histone modifications, spe-
cifically histone acetylation, are also involved.
The text in this review has been selective in discussing 
the field and the reader is advised to consult Tables 2 and 
3 for a more comprehensive appreciation of the wider lit-
erature review.
Conclusions and future perspectives
The results of our systematic literature assessment demon-
strate a growing interest in the contribution of histone mod-
ifications in regulating the development of allergic disorders 
and, at the same time, provide evidence supporting this con-
tribution. The role of histone modification is manifested at 
least at two levels. One involves the regulation of cells par-
ticipating in the allergic inflammatory reaction, namely the 
inflammatory cells, T cells and macrophages, and the local 
tissue cells, such as (myo-) fibroblasts, which contribute to 
remodeling of airways. The other is the direct relationships 
between histone modifications and allergic phenotypes.
Furthermore, experimental observations of effects of 
histone marks modifying substances, e.g. HDACis or 
HMTis, suggest the potential application of histone epi-
genome editing in the treatment of allergies [35, 86–92]. 
Such therapies do not need to be simply restricted to his-
tone-modifying enzyme inhibitors but may also include 
more targeted approaches based on e.g. CRISPR/dCas9 
system [6, 92] or antisense molecules [6, 93–95]. Others 
include nutrients [71] or even bio-physical interventions 
[96]. Finally, also diagnostic/prognostic tools for allergic 
traits based on epigenetic patterns/signatures could pos-
sibly be developed in future, as suggested by several stud-
ies on DNA methylation [6, 97–99].
This review provides a systematic update of the cur-
rent knowledge on the contribution of histone modifi-
cations to allergic inflammation and disorders.
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